Patent holdings for IPC class C07D 267/02

Total number of patents in this class: 30

10-year publication summary

5
2
0
0
2
2
4
3
0
0
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4811
5
Rigel Pharmaceuticals, Inc.
509
5
Gilead Sciences, Inc.
2189
2
Theravance Biopharma R&D IP, LLC
425
2
Glaxo Group Limited
4364
1
Novartis AG
10327
1
Amgen Inc.
4357
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
744
1
Daya Drug Discoveries, Inc.
7
1
Enanta Pharmaceuticals, Inc.
431
1
Janssen Sciences Ireland UC
167
1
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
351
1
KemPharm, Inc.
27
1
KYORIN Pharmaceutical Co., Ltd.
162
1
Novira Therapeutics, Inc.
32
1
Shanghai Hansoh Biomedical Co., Ltd.
327
1
Inogent Laboratories Private Limited
6
1
NMD Pharma A/S
46
1
Praxis Precision Medicines, Inc.
218
1
Merck Sharp & Dohme LLC
3729
1
Other owners 0